Cite
APA Citation
von Spee-Mayer, C., Siegert, E., Abdirama, D., Rose, A., Klaus, A., Alexander, T., Enghard, P., Sawitzki, B., Hiepe, F., Radbruch, A., Burmester, G., Riemekasten, G., & Humrich, J. Y. (2016). low-dose interleukin-2 selectively corrects regulatory T cell defects in patients with systemic lupus erythematosus. Annals of the rheumatic diseases, 75(7), 1407–1415. http://access.bl.uk/ark:/81055/vdc_100135559012.0x000064